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ABSTRACT
Mantle cell lymphoma (MCL) is a malignant B-cell neoplasm, which comprises monomorphic and small- to medium-sized 
mantle zone-derived lymphoid cells. It is characterized by chromosomal translocation t(11;14)(q13;q32) and 
CCND1 truncation, resulting in cell cycle deregulation. It is an aggressive type of non-Hodgkin lymphoma with a propensity 
to present with extranodal involvement. This study shows the case of an 80-year-old Caucasian male who complained of 
a 2-month progressive swelling on the right side of his face. The magnetic resonance imaging exam showed multifocal 
involvement of the head and neck, including oral manifestations, bilateral parotid glands, palate, tongue, and floor of 
the mouth. An incisional biopsy of the tumor mass was performed. The morphological and immunophenotypic findings 
were consistent with the diagnosis of MCL. The patient died 4 months later, without any chance of undergoing a 
therapeutic approach. Although MCL is a rare condition, it should be subjected to a differential diagnosis when affecting 
the maxillofacial area. Imaging exams and both immunohistochemical and morphological analyses are needed to reach 
the correct diagnosis. Here, we present an unusual MCL with multifocal involvement of the head and neck. 
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INTRODUCTION
Non-Hodgkin lymphoma (NHL) most commonly 
presents in extranodal sites; that is, the gastrointestinal 
tract, followed by the head and neck region (especially 
Waldeyer’s ring), which are the most frequent locations of 
involvement.1-4 In the oral cavity, NHL is rare, accounting 
for less than 5% of all oral malignant neoplasms.4,5
Mantle cell lymphoma (MCL) represents 6% of 
all NHLs,1,2 which comprises monomorphic and small 
to medium-sized mantle-zone-derived lymphoid cells. 
It is characterized by chromosomal translocation 
t (11;14)(q13;q32) and CCND1 truncation, resulting 
in cell cycle deregulation.1,6,7 MCL is prevalent in male 
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individuals during adulthood and affects patients 
in the sixth and seventh decades of life.2,5 Patients 
are usually diagnosed in the advanced stages of the 
disease, confirming the aggressive behavior of MCL.1,2
Few cases of MCL in the oral cavity have been 
reported, and most of them include the involvement 
of the palate and the tongue.8-10 Salivary glands are 
rarely affected, accounting for only 3% of the reported 
cases.7 Magnetic resonance imaging (MRI) is the 
method of choice for evaluating NHL, which assesses 
the exact tumor extension, the possible local and 
distant involvement, and the nodal status.7,11
The purpose of this study was to report the case 
of an extensive MCL that affected both the nodal and 
the extranodal sites in the head and neck region, as 
observed in MRI scans. To our knowledge, this is the 
first report of a multifocal MCL in the maxillofacial 
region.
CASE REPORT
An 80-year-old Caucasian man was referred to the 
Stomatology Department, because he presented with 
a swelling on the right side of his face, which he first 
noticed 2 months earlier. His medical history included 
chronic renal failure.
The extraoral examination revealed a swelling 
of the right parotid gland and the submandibular 
gland, as well as an extensive ipsilateral cervical 
lymphadenopathy. On intraoral examination, two 
masses were observed: one on the left side of the 
palate and the other on the floor of the mouth 
(Figure 1). Tongue mobility was normal and there was 
no evidence of paresthesia of the lingual nerve.
Examination of the right parotid gland by MRI 
revealed a solid and expansive mass in the superficial 
lobe, which was characterized by a hyposignal and 
a hypersignal on a T1-weighted image (T1W) and a 
T2-weighted image (T2W), respectively. Another two 
nodular masses were observed in the inferior pole of 
the parotid gland. MRI also examined the contralateral 
parotid gland, and three small nodular masses were 
observed in the superficial lobe, which presented 
signal features similar to those on the right side. 
Moreover, a mass involving the left side of the palate 
showed continuity, with an ipsilateral narrowing of the 
pharyngeal airspace (Figure 2A and 2B). The posterior 
two-thirds of the tongue (left side) and both lingual 
tonsils showed expansive lesions. The epiglottis was 
posteriorly displaced and the vallecula was obliterated, 
leading to narrowing of the pharyngeal airspace 
(Figure 2C). Evidence of expansive masses was also 
noted on the floor of the mouth and in both sublingual 
and submandibular areas, without affecting the 
salivary glands. Bilateral lymphadenopathy was also 
observed, in contrast with the clinical examination 
Figure 1. Clinical presentation of mantle cell lymphoma. A – The right parotid gland and submandibular regions are 
affected; B – A tumor mass is observed intraorally on the left side of the floor of the mouth.
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findings (Figure 2D). Considering the clinical and 
imaging findings, the working diagnosis pointed to a 
malignant disease.
An incisional biopsy was performed on the 
floor of the mouth, and the histopathological 
examination showed a monotonous proliferation of 
small- to medium-sized lymphocytes, with slightly 
irregular nuclei and moderately dispersed chromatin. 
The growth pattern was predominantly diffuse, in 
contrast with a sparsely nodular pattern. Also, focal 
hyalinized vessels and scarce epithelioid histiocytes 
were observed. An immunohistochemical analysis 
revealed neoplastic cells, which were positive for CD20, 
CD5, and cyclin D1, but negative for CD3, CD4, and 
CD23 (Figure 3). The final diagnosis was MCL, and the 
patient died 4 months later.
The patient signed an informed consent.
Figure 2. Cervical MRI: Axial view of: A – T1W image; B – T2W image. (1) Superficial lobe of the right parotid 
gland affected by the MCL. (2) Nodular formations in the superficial lobe of the left parotid gland. (3) Expansive 
lesion in the palate; C – Sagittal view of T1W image showing a tumor mass affecting the palate and its continuity 
to the pharyngeal airspace; D – Coronal view of T2W image showing the involvement of cervical lymph nodes. 
MRI = magnetic resonance imaging; T1W = T1-weighted; T2W = T2-weighted.
Marcucci M, Marcucci G, Cordeiro MS, et al.
29Autops Case Rep (São Paulo). 2017;7(3):26-31
DISCUSSION
NHL is considered the third most common 
malignancy in the oral cavity, although it accounts 
for less than 5% of all oral cancers. MCL is a rare and 
aggressive form of NHL, affecting adults ranging from 
middle age to older, with male predominance.2-5,10 
The clinical course of MCL varies from an indolent 
disease to a rapidly progressive malignancy. A tumor 
mass, with or without ulceration, is the most common 
manifestation found in the oral cavity.6,8
The parotid glands are the major sal ivary 
glands most often affected by MCL.3,4,7,8,12,13 
Primary presentation of MCL within the oral cavity 
is uncommom.4,8,12 Usually, MCL presents as a 
stage-III/IV disease at the time of diagnosis, with 
extranodal involvement, especially in the bone narrow, 
peripheral blood, gastrointestinal tract, spleen, and 
Waldeyer’s ring.1,8 Extranodal manifestations can 
be challenging for clinicians, since they may be 
multifocal manifestations of NHL in advanced stages, 
such as Burkitt lymphoma. In addition, there are two 
subgroups; namely, diffuse large B-cell lymphoma 
(DLBCL) and extranodal marginal zone B-cell lymphoma 
of the mucosa-associated lymphoid tissue (MALT), in 
which patients present with the involvement of several 
extranodal sites.14 As well as the aforementioned 
considerations, this case report includes both nodal 
and extranodal involvement by MCL in the head and 
neck with multifocal oral manifestation, which is 
extremely unusual.
Diagnosis of MCL requires both morphological 
and immunophenotypic analysis. Immunohistochemical 
analysis usually shows positivity for CD20, CD5, CD43, 
Figure 3. Photomicrography of the biopsy specimen. A – Monotonous lymphoid proliferation of small- to 
medium-sized lymphocytes (H&E, 100X); B, C, and D – Immunohistochemical profile showing positivity for CD20, 
CD5, and cyclin D1 in the neoplastic cells (400X).
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and remarkably cyclin D1, as well as immunoglobulin 
IgM and/or IgD. Moreover, SOX11 was identified to be 
exclusively overexpressed in MCL, including the cyclin 
D1-negative cases; however, MCL is negative for CD10, 
CD23, and BCL6.7-9,15 Furthermore, chromosomal 
translocation t(11;14)(q13;q32) and the presence 
of cyclin D1 (CCND1/PRAD1) genes in almost all 
cases is considered to be the primary genetic event. 
As a result, overexpression of the cyclin D1 protein 
is thought to lead to deregulation of the normal cell 
cycle, particularly in the G1/S phase transition.1,6,7,15,16 
As indicated by morphological evaluation, most lesions 
exhibit cytologic features resembling centrocytes. 
A small subset may show blastoid or pleomorphic 
features, which are often associated with aggressive 
clinical behavior.8,16 The current case showed the 
cellular features of a classic variant of MCL, with a 
predominantly diffuse growth pattern and typical 
immunohistochemical findings, which confirmed the 
diagnosis.
Of all the available imaging methods, MRI offers 
the best soft tissue contrast and spatial resolution, 
with the advantage of not using ionizing radiation.11 
For patients with palpable masses in the parotid 
gland area, MRI is the gold standard method, due to 
its precision in assessing the exact extension of the 
mass, the possible invasion of adjacent structures, the 
perineural spread, and the lymph node staging.7,11,12 
Lymphomas exhibit homogenous signal patterns, with 
hyposignal and hypersignal intensities in T1W and 
T2W images, respectively.7,12 The clinical features and 
MRI findings of the current case study highlight the 
potential of MCL to disseminate—of which physicians 
should be aware—based on the suggestive multifocal 
manifestation of the disease.
MCL is characterized by an aggressive clinical 
course and a poor prognosis.1,6,7,8 The MCL International 
Prognostic Index (MIPI) stratifies the risk by taking 
into account the clinical and laboratory features, and 
classifies the patients into low, intermediate, and 
high-risk groups.1,6 Regardless of the MIPI classification, 
only 5%–10% of patients survive longer than 3 years.8,15 
The heterogeneous biological behavior of the disease 
makes it difficult to establish a treatment of choice.1,15 
Treatment varies from chemotherapy to a combination 
of chemotherapy and radiotherapy.8,10 Improvements 
in treatment have been achieved by using conventional 
chemotherapy together with autologous stem cell 
transplantation. However, no standard treatment 
for patients with MCL is currently available, and the 
disease is still considered to be incurable.6 Relatively 
few patients (30%) have a complete response to 
combination chemotherapy.15 The case reported herein 
presented an advanced stage of the disease at the 
time of diagnosis, and the patient unfortunately died 
before any treatment planning could be scheduled, 
thus confirming the poor prognosis of MCL.
CONCLUSION
This case report presents an unusual case of MCL 
with multifocal involvement in the head and neck 
region, including oral manifestation in the palate, 
tongue, and floor of the mouth. Although a rare 
condition, MCL should be subjected to differential 
diagnosis when it affects the maxillofacial area. Imaging 
exams plus morphological and immunophenotypic 
analyses are needed to establish the correct diagnosis. 
However, the diagnosis of MCL can be challenging 
because of its similarities to other types of NHL.
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